Mitoguazone

CAS : 459-86-9

Ref. TM-T35617

Informations sur le produit

• Nom: Mitoguazone
• Synonymes: MGBG, Methyl-GAG, 1,1'-((Methylethanediylidene)dinitrilo)diguanidine, 2,2′-(1-Methyl-1,2-ethanediylidene)bis[hydrazinecarboximidamide], Ai3-60317, Brn 1912590, Guanidine, 1,1'-((methylethanediylidene)dinitrilo)di-, Hydrazinecarboximidamide, 2,2'-(1-methyl-1,2-ethanediylidene)bis- (9CI), Hydrazinecarboximidamide, 2,2′-(1-methyl-1,2-ethanediylidene)bis-, Me-GAG, Methyl-G, Methyl-Gag, Methylglyoxal bis(amidinohydrazone), Methylglyoxal bis(guanylhydrazone), Mitoguanazone, Mitoguazona, Mitoguazona [INN-Spanish], Mitoguazone [INN:DCF], Mitoguazonum, Mitoguazonum [INN-Latin], N''-{(1E,2E)-2-[(diaminomethylidene)hydrazono]-1-methylethylidene}carbonohydrazonic diamide (non-preferred name), NSC 32946, Pyruvaldehyde bis(amidinohydrazone), Unii-Od5Q0L447W

Description

Mitoguazone is an antitumor agent, blocking SAM decarboxylase, disrupting polyamine synthesis, and hindering HIV DNA integration in immune cells.

• Marque: Targetmol

Propriétés chimiques

• Masse moléculaire: 184.2
• Formule: C₅H₁₂N₈
• Degré de pureté: 98%
• Couleur/Forme: Solid